Aclarion receives U.S. patent on expanded applications of MRS data processing

Aclarion (ACON) has received a Notice of Allowance from the United States Patent and Trademark Office for its 24th issued US patent. Whereas previous issued patents in the Aclarion portfolio limit the use of propionic acid identification by magnetic resonance spectroscopy to the disc, this new patent expands Aclarion’s ability to use MRS to identify PA throughout the body to identify potential sources of infection and pain.